Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

36.82 +0.06 (+0.16%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Why Shares of Harmony Bioscience Are Slumping Tuesday ↗
A short-seller report drove the stock's shares down. 
Via The Motley Fool
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Harmony Biosciences Holdings, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
EQUITY ALERT: Rosen Law Firm Encourages Harmony Biosciences Holdings, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – HRMY
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Harmony Biosciences ↗
 
Via Benzinga
News headline image
With This Big Transition Ahead, Is Novavax a Buy? ↗
Novavax stock sank 92% last year. 
Via The Motley Fool
News headline image
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
HRMY Stock Alert: Scorpion Short Report Sends Harmony Plunging ↗
Scorpion Capital has issued a short report on HRMY stock, alleging that the company's Wakix drug is not safe for the public. 
Via InvestorPlace
News headline image
Stocks Mixed After Upbeat Consumer Confidence Data ↗
The Dow Jones Industrial Average managed to swing into positive territory this afternoon, though the S&P 500 Index and Nasdaq Composite Index are still sitting in the red. 
Via Talk Markets
News headline image
Dow Rises 50 Points; Harmony Biosciences Shares Plunge ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday. The Dow traded up 0.16% to 32,484.24 while the NASDAQ fell 0.75% to 11,681.12. The S&P 500, also... 
Via Benzinga
News headline image
EXCLUSIVE: Harmony Bio Responds To Short Report, Tells Benzinga It Disagrees With Assertions ↗
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) shares fell almost 20% after Scorpion Capital filed a Citizen's Petition with the FDA requesting the withdrawal of approval of Wakix (pitolisant). 
Via Benzinga
News headline image
Nasdaq Down Over 50 Points; US Goods Trade Deficit Widens Slightly ↗
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.01% to 32,436.22 while the NASDAQ fell... 
Via Benzinga
News headline image
Short Seller Report On Harmony Biosciences: Here's Why The Stock Is Tanking ↗
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) shares are trading lower after Scorpion Capital filed a Citizen's Petition with the FDA requesting the withdrawal of approval of Wakix (pitolisant). 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
7 Healthcare Stocks to Buy for Long-Term Growth and Stability ↗
These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio as we get deeper into 2023. 
Via InvestorPlace
News headline image
Harmony Biosciences (HRMY) Q4 2022 Earnings Call Transcript ↗
HRMY earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist ↗
The company offered neither financial guidance nor plans for a new CEO. 
Via Investor's Business Daily
News headline image
Big Retailers Report ↗
Good Morning Everyone! Customers are setting banks on fire in Lebanon because they can’t get their money out. Inflation is at +170%. This is what a currency collapse looks like: 
Via Benzinga
News headline image
Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
News headline image
Alkermes Stock Sees Rising Relative Price Strength ↗
The Relative Strength (RS) Rating for Alkermes stock entered a new percentile Friday, with an increase from 79 to 86. 
Via Investor's Business Daily
News headline image
Anavex Life Sciences Stock Shows Improved Price Strength Rating ↗
Anavex Life Sciences stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75. 
Via Investor's Business Daily
News headline image
The 7 Best Biotech Stocks to Buy for February 2023 ↗
Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential. 
Via InvestorPlace
News headline image
7 Healthcare Stocks That Will Be Big Winners in 2023 ↗
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider. 
Via InvestorPlace
News headline image
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today ↗
The stock has gone on a wild ride over the past few years. 
Via The Motley Fool
News headline image
2 Biotechs Making Waves With A Single Product in their Pipeline
Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise. 
Via MarketBeat
News headline image
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. 
Via Benzinga
News headline image
NVAX Stock Alert: What to Know as Novavax Names New CEO ↗
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries. 
Via InvestorPlace
News headline image
Moderna Stock Shows Surprising Strength; Key Rating Upgraded ↗
See if Moderna stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day average. 
Via Investor's Business Daily
News headline image
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating ↗
On Thursday, China-based BeiGene stock cleared that desired 80-plus benchmark, with a jump to 82 from 77 a day earlier. 
Via Investor's Business Daily
News headline image
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade ↗
Xenon Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded to 92 Tuesday, up from 89 a day earlier. 
Via Investor's Business Daily
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.